{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:48:38Z","timestamp":1791953318643,"version":"4.3.4"},"reference-count":73,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-14-00458"],"award-info":[{"award-number":["24-14-00458"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"award":["24-14-00458"],"award-info":[{"award-number":["24-14-00458"]}],"id":[{"id":"https:\/\/ror.org\/03y2gwe85","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>The pursuit of efficient approaches for the production of promising antiviral and cytostatic pharmaceuticals is a crucial direction in medical biotechnology, especially after the COVID-19 pandemic. Modified nucleosides and nucleotides represent a highly promising class of chemicals for the development of drugs against cancer and viral infections. Being an alternative to traditional chemical synthesis, cascades of nucleic exchange enzymes offer single-step synthesis of such compounds with exceptional stereo- and regioselectivity. Furthermore, employing thermostable enzymes for such cascades offers the advantages of increased substrate solubility, lower solution viscosity, prevention of contamination, and simplified biocatalyst purification via thermal denaturation. The first biocatalyst for two distinct cascade pathways of nucleotide and nucleoside synthesis is ribokinase. In this article, we report improving the activity of ribokinase from Thermus sp. 2.9 (TspRK) for the cascade synthesis of modified nucleosides and nucleotides. We have employed a rational design approach, including Boltz-2 modeling and sequence conservation analysis. We have engineered two mutants, T244I and N272H, achieving a 3-fold increase in ribose phosphorylation rate (kcat). Improving the enzymatic activity of a thermostable ribokinase will serve as the basis for further optimization of cascade synthesis of pharmaceutical modified nucleosides and nucleotides.<\/jats:p>","DOI":"10.3390\/ijms27198911","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:40:17Z","timestamp":1791596417000},"page":"8911","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing the Activity of Ribokinase from Thermus sp. 2.9 Through Rational Design for the Cascade Synthesis of Modified Nucleotides and Nucleosides"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-7385","authenticated-orcid":false,"given":"Evgeniy A.","family":"Zayats","sequence":"first","affiliation":[{"name":"Shemyakin\u2013Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9904-1539","authenticated-orcid":false,"given":"Yulia A.","family":"Abramchik","sequence":"additional","affiliation":[{"name":"Shemyakin\u2013Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6768-8995","authenticated-orcid":false,"given":"Maria A.","family":"Kostromina","sequence":"additional","affiliation":[{"name":"Shemyakin\u2013Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8571-4197","authenticated-orcid":false,"given":"Ilya V.","family":"Fateev","sequence":"additional","affiliation":[{"name":"Shemyakin\u2013Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Karanov","sequence":"additional","affiliation":[{"name":"Shemyakin\u2013Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"},{"name":"Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra R.","family":"Sharafutdinova","sequence":"additional","affiliation":[{"name":"Shemyakin\u2013Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6763-1642","authenticated-orcid":false,"given":"Vasiliy A.","family":"Ptushkin","sequence":"additional","affiliation":[{"name":"Shemyakin\u2013Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5563-6549","authenticated-orcid":false,"given":"Irina D.","family":"Konstantinova","sequence":"additional","affiliation":[{"name":"Shemyakin\u2013Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8908-4268","authenticated-orcid":false,"given":"Andrey V.","family":"Golovin","sequence":"additional","affiliation":[{"name":"Shemyakin\u2013Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"},{"name":"Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman S.","family":"Esipov","sequence":"additional","affiliation":[{"name":"Shemyakin\u2013Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"},{"name":"Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/bit.28395","article-title":"Driving adoption of new technologies in biopharmaceutical manufacturing","volume":"120","author":"Schaefer","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.tibtech.2024.10.014","article-title":"A snapshot of biomanufacturing and the need for enabling research infrastructure","volume":"43","author":"Fawcett","year":"2025","journal-title":"Trends Biotechnol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sha, A., Liu, Y., and Hao, H. (2023). Current state-of-the-art and potential future therapeutic drugs against COVID-19. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1238027"},{"key":"ref_4","first-page":"100208","article-title":"Clinical development of antivirals against SARS-CoV-2 and its variants","volume":"6","author":"Lan","year":"2024","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1126\/science.abn1900","article-title":"Stopping pandemics before they start: Lessons learned from SARS-CoV-2","volume":"375","author":"Edwards","year":"2022","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Outteridge, M., Nunn, C.M., Devine, K., Patel, B., and McLean, G.R. (2024). Antivirals for broader coverage against human coronaviruses. Viruses, 16.","DOI":"10.3390\/v16010156"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e202300921","DOI":"10.1002\/cbdv.202300921","article-title":"Recent efforts in identification of privileged scaffolds as antiviral agents","volume":"20","author":"Yadav","year":"2023","journal-title":"Chem. Biodivers."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12672-024-01195-7","article-title":"Novel therapeutic agents in clinical trials: Emerging approaches in cancer therapy","volume":"15","author":"Joshi","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"116925","DOI":"10.1016\/j.ejmech.2024.116925","article-title":"Breakthroughs in AI and multi-omics for cancer drug discovery: A review","volume":"280","author":"Fatima","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"113233","DOI":"10.1016\/j.ejmech.2021.113233","article-title":"Advance of structural modification of nucleosides scaffold","volume":"214","author":"Lin","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1002\/cpz1.376","article-title":"An overview of marketed nucleoside and nucleotide analogs","volume":"2","author":"Herdewijn","year":"2022","journal-title":"Curr. Protoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(02)00788-X","article-title":"Nucleoside analogues and nucleobases in cancer treatment","volume":"3","author":"Galmarini","year":"2002","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Geraghty, R.J., Aliota, M.T., and Bonnac, L.F. (2021). Broad-spectrum antiviral strategies and nucleoside analogues. Viruses, 13.","DOI":"10.3390\/v13040667"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"108889","DOI":"10.1016\/j.carres.2023.108889","article-title":"Nucleoside analogues: N-glycosylation methodologies, synthesis of antiviral and antitumor drugs and potential against drug-resistant bacteria and Alzheimer\u2019s disease","volume":"532","author":"Maria","year":"2023","journal-title":"Carbohydr. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/cmdc.202000849","article-title":"Advances in nucleoside and nucleotide analogues in tackling human immunodeficiency virus and hepatitis virus infections","volume":"16","author":"Ramesh","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.1007\/s12274-024-6978-6","article-title":"mRNA medicine: Recent progresses in chemical modification, design, and engineering","volume":"17","author":"Hou","year":"2024","journal-title":"Nano Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Burton, K., and Dellinger, K. (2026). Chemical modification strategies for therapeutic oligonucleotides: Mechanism compatibility, design trade-offs, and translational barriers. Molecules, 31.","DOI":"10.3390\/molecules31152588"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/jacsau.2c00481","article-title":"Biocatalytic synthesis of antiviral nucleosides, cyclic dinucleotides, and oligonucleotide therapies","volume":"3","author":"Thompson","year":"2023","journal-title":"JACS Au"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1039\/D5SC03026A","article-title":"Preparation of nucleoside analogues: Opportunities for innovation at the interface of synthetic chemistry and biocatalysis","volume":"16","author":"Salihovic","year":"2025","journal-title":"Chem. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102873","DOI":"10.1016\/j.copbio.2022.102873","article-title":"Biocatalytic cascade transformations for the synthesis of C-nucleosides and N-nucleoside analogs","volume":"79","author":"Pfeiffer","year":"2023","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Capecchi, E., Tomaino, E., Onnelli, G., Ubertini, V., and Saladino, R. (2026). Nature-inspired enzymatic cascades: Emerging strategies for sustainable chemistry. Molecules, 31.","DOI":"10.3390\/molecules31040603"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Fehlau, M., Westarp, S., Neubauer, P., and Kurreck, A. (2025). Advances in the enzymatic synthesis of nucleoside-5\u2032-triphosphates and their analogs. Catalysts, 15.","DOI":"10.3390\/catal15030270"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.32607\/20758251-2010-2-2-36-58","article-title":"New trends in nucleoside biotechnology","volume":"2","author":"Mikhailopulo","year":"2010","journal-title":"Acta Naturae"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nchembio.1494","article-title":"Bioretrosynthetic construction of a didanosine biosynthetic pathway","volume":"10","author":"Birmingham","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aay8484","article-title":"Design of an in vitro biocatalytic cascade for the manufacture of islatravir","volume":"366","author":"Huffman","year":"2019","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s44160-024-00671-w","article-title":"An engineered aldolase enables the biocatalytic synthesis of 2\u2032-functionalized nucleoside analogues","volume":"4","author":"Willmott","year":"2025","journal-title":"Nat. Synth."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1021\/acscentsci.1c00608","article-title":"Engineered ribosyl-1-kinase enables concise synthesis of molnupiravir, an antiviral for COVID-19","volume":"7","author":"McIntosh","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1021\/jacs.1c11048","article-title":"An engineered cytidine deaminase for biocatalytic production of a key intermediate of the COVID-19 antiviral molnupiravir","volume":"144","author":"Burke","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1134\/S1068162025604471","article-title":"Mutant forms of nucleoside phosphorylases and other nucleic acid metabolism enzymes for the optimization of cascade synthesis of modified nucleosides","volume":"52","author":"Zayats","year":"2026","journal-title":"Russ. J. Bioorg. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Fateev, I.V., Kostromina, M.A., Abramchik, Y.A., Eletskaya, B.Z., Mikheeva, O.O., Lukoshin, D.D., Zayats, E.A., Berzina, M.Y., Dorofeeva, E.V., and Paramonov, A.S. (2021). Multi-enzymatic cascades in the synthesis of modified nucleosides: Comparison of the thermophilic and mesophilic pathways. Biomolecules, 11.","DOI":"10.3390\/biom11040586"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.32607\/20758251-2016-8-4-82-90","article-title":"A cascade of thermophilic enzymes as an approach to the synthesis of modified nucleotides","volume":"8","author":"Esipov","year":"2016","journal-title":"Acta Naturae"},{"key":"ref_32","first-page":"100137","article-title":"Residues of the ribose-binding site are required for human ribokinase activity","volume":"12","author":"Ferreira","year":"2025","journal-title":"J. Struct. Biol. X"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"148382","DOI":"10.1016\/j.ijbiomac.2025.148382","article-title":"Structural and biochemical insights into the molecular mechanism of ribokinase RBK1 from Saccharomyces cerevisiae","volume":"331","author":"Zhen","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijbiomac.2019.06.001","article-title":"Unraveling structural insights of ribokinase from Leishmania donovani","volume":"136","author":"Gatreddi","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1107\/S2053230X18000109","article-title":"Ribokinase from Leishmania donovani: Purification, characterization and X-ray crystallographic analysis","volume":"74","author":"Gatreddi","year":"2018","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zayats, E.A., Fateev, I.V., Kostromina, M.A., Abramchik, Y.A., Lykoshin, D.D., Yurovskaya, D.O., Timofeev, V.I., Berzina, M.Y., Eletskaya, B.Z., and Konstantinova, I.D. (2022). Rational mutagenesis in the lid domain of ribokinase from Escherichia coli results in an order-of-magnitude increase in activity towards D-arabinose. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012540"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jsb.2019.02.007","article-title":"Crystal structure and mutational analyses of ribokinase from Arabidopsis thaliana","volume":"206","author":"Kang","year":"2019","journal-title":"J. Struct. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cbic.200900620","article-title":"Five-component cascade synthesis of nucleotide analogues in an engineered self-immobilized enzyme aggregate","volume":"11","author":"Scism","year":"2010","journal-title":"ChemBioChem"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12969","DOI":"10.1039\/D5SC00852B","article-title":"Construction of the reduced nicotinamide adenine dinucleotide salvage pathway in artificial cells and its application in amino acid synthesis","volume":"16","author":"Liu","year":"2025","journal-title":"Chem. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1038\/s41467-020-20035-0","article-title":"Reverse C-glycosidase reaction provides C-nucleotide building blocks of xenobiotic nucleic acids","volume":"11","author":"Pfeiffer","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_41","first-page":"101127","article-title":"Phosphorylation-condensation cascade for biocatalytic synthesis of C-nucleosides","volume":"4","author":"Ribar","year":"2024","journal-title":"Chem Catal."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.synbio.2026.03.013","article-title":"Systematic metabolic engineering of Escherichia coli for high-level production of pseudouridine via pathway optimization and precursor enhancement","volume":"14","author":"Song","year":"2026","journal-title":"Synth. Syst. Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e202506330","DOI":"10.1002\/anie.202506330","article-title":"Integrated chemoenzymatic synthesis of the mRNA vaccine building block N1-methylpseudouridine triphosphate","volume":"64","author":"Pfeiffer","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17148","DOI":"10.1002\/anie.202105667","article-title":"Identification of a pyrrole intermediate which undergoes C-glycosidation and autoxidation to yield the final product in showdomycin biosynthesis","volume":"60","author":"Ren","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10968","DOI":"10.1021\/jacs.2c04080","article-title":"Characterization of the oxazinomycin biosynthetic pathway revealing the key role of a nonheme iron-dependent mono-oxygenase","volume":"144","author":"Ren","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12934-021-01722-z","article-title":"Biosynthesis of C-nucleoside antibiotics in actinobacteria: Recent advances and future developments","volume":"21","author":"Zhang","year":"2022","journal-title":"Microb. Cell Fact."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/cb400384c","article-title":"Chemoenzymatic synthesis of novel C-ribosylated naphthoquinones","volume":"8","author":"Blauenburg","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s43141-023-00494-w","article-title":"Thermostable enzyme research advances: A bibliometric analysis","volume":"21","author":"Leong","year":"2023","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1134\/S1063774521050205","article-title":"Three-dimensional structure of recombinant thermophilic ribokinase from Thermus species 2.9 in complex with adenosine diphosphate","volume":"66","author":"Timofeev","year":"2021","journal-title":"Cryst. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Roy, S., Vivoli Vega, M., and Harmer, N.J. (2019). Carbohydrate kinases: A conserved mechanism across differing folds. Catalysts, 9.","DOI":"10.3390\/catal9010029"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"140109","DOI":"10.1016\/j.ijbiomac.2025.140109","article-title":"Conformational flexibility of human ribokinase captured in seven crystal structures","volume":"299","author":"Akanmori","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0969-2126(98)00020-3","article-title":"Structure of Escherichia coli ribokinase in complex with ribose and dinucleotide determined to 1.8 \u00c5 resolution: Insights into a new family of kinase structures","volume":"6","author":"Sigrell","year":"1998","journal-title":"Structure"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/jmbi.2001.5248","article-title":"Activation of ribokinase by monovalent cations","volume":"315","author":"Andersson","year":"2002","journal-title":"J. Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Vang H\u00f8st, A., and Berglund, P. (2026). Assessing enzyme stability for biocatalysis. Biocatal. Biotransform., 1\u201325.","DOI":"10.1080\/10242422.2026.2686656"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1110\/ps.0240003","article-title":"Protein stability induced by ligand binding correlates with changes in protein flexibility","volume":"12","author":"Celej","year":"2003","journal-title":"Protein Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0141-8130(95)01082-3","article-title":"Thermal stability of Artemia HGPRT: Effect of substrates on inactivation kinetics","volume":"18","author":"Montero","year":"1996","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1021\/acscatal.3c05059","article-title":"Designing an efficient biocatalyst for the phosphoribosylation of antiviral pyrazine-2-carboxamide derivatives","volume":"14","author":"Zayats","year":"2024","journal-title":"ACS Catal."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antivir. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1124\/mol.113.087247","article-title":"Role of human hypoxanthine guanine phosphoribosyltransferase in activation of the antiviral agent T-705 (favipiravir)","volume":"84","author":"Naesens","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1021\/acs.jmedchem.8b00617","article-title":"Prodrugs of the phosphoribosylated forms of hydroxypyrazinecarboxamide pseudobase T-705 and its de-fluoro analogue T-1105 as potent influenza virus inhibitors","volume":"61","author":"Huchting","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_62","first-page":"1","article-title":"Improving properties of the nucleobase analogs T-705\/T-1105 as potential antivirals","volume":"57","author":"Meier","year":"2021","journal-title":"Annu. Rep. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Ganter, B., Zickler, M., Huchting, J., Winkler, M., L\u00fcttjohann, A., Meier, C., Gabriel, G., and Beck, S. (2023). T-705-derived prodrugs show high antiviral efficacies against a broad range of influenza A viruses with synergistic effects when combined with oseltamivir. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15061732"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"104746","DOI":"10.1016\/j.jbc.2023.104746","article-title":"Screening the Thermotoga maritima genome for new wide-spectrum nucleoside and nucleotide kinases","volume":"299","author":"Winkler","year":"2023","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1128\/JB.01136-12","article-title":"Diversity and versatility of the Thermotoga maritima sugar kinome","volume":"194","author":"Rodionova","year":"2012","journal-title":"J. Bacteriol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/nar\/gkf436","article-title":"MAFFT: A novel method for rapid multiple sequence alignment based on fast Fourier transform","volume":"30","author":"Katoh","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: A sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Passaro, S., Corso, G., Wohlwend, J., Reveiz, M., Thaler, S., Somnath, V.R., Getz, N., Portnoi, T., Roy, J., and Stark, H. (2025). Boltz-2: Towards accurate and efficient binding affinity prediction. bioRxiv.","DOI":"10.1101\/2025.06.14.659707"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Wohlwend, J., Corso, G., Passaro, S., Getz, N., Reveiz, M., Leidal, K., Swiderski, W., Atkinson, L., Portnoi, T., and Chinn, I. (2024). Boltz-1: Democratizing biomolecular interaction modeling. bioRxiv.","DOI":"10.1101\/2024.11.19.624167"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: Making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat. Methods"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8911\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:17:46Z","timestamp":1791951466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":73,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198911"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198911","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}